Frequently Asked Questions
Common Questions About Using ICD-10 Code E74.820 for SLC13A5 Citrate Transporter Disorder
What are the common symptoms of SLC13A5 Citrate Transporter Disorder?
Common symptoms include metabolic acidosis, growth delays, and recurrent kidney stones. Patients may also experience fatigue and abdominal discomfort due to metabolic imbalances.
How is SLC13A5 Citrate Transporter Disorder diagnosed?
Diagnosis is typically made through clinical evaluation, family history, and genetic testing to identify mutations in the SLC13A5 gene, along with metabolic assessments.
What treatment options are available for SLC13A5 Citrate Transporter Disorder?
Treatment primarily involves oral bicarbonate supplementation to correct metabolic acidosis, dietary modifications, and regular monitoring of metabolic status and renal function.
Is SLC13A5 Citrate Transporter Disorder hereditary?
Yes, SLC13A5 Citrate Transporter Disorder is an autosomal recessive genetic condition, meaning that both parents must carry a mutation for a child to be affected.
